Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 16 Aug 2024 02:32:04 +0200Thu, 27 Jun 2024 11:54:00 +0200Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 33, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/eyleaHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 33, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/eyleaThu, 27 Jun 2024 11:54:00 +0200Human medicineEylea-H-C-2392-PSUV-0011 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500171792_en.pdfEylea-H-C-2392-PSUV-0011 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500171792_en.pdfThu, 28 Aug 2014 02:00:00 +0200Human medicine